Eliane M. Billaud - Concepedia

Author

Eliane M. Billaud

Also Known As

E Billaud, E M Billaud, E. Billaud, E. M. Billaud, E.M Billaud, E.M. Billaud, Eliane Billaud, Eliane M Billaud, Eliane M. Billaud, Eliane M. Billaud

116

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Hôpital Européen Georges-Pompidou Université Paris Cité Hôpital Européen Assistance Publique – Hôpitaux de Paris Délégation Paris 5

About

Eliane M. Billaud is an author at Hôpital Européen Georges-Pompidou specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	25	1.1K
2	Engineering	1	1	92
3	Public Health	1	1	73
4	Social Sciences	1	1	28
5	Biochemistry	1	1	37

Eliane M. Billaud

Publications

Citations

H-Index

Page 1

	Year	Citations
Carotid artery distensibility and distending pressure in hypertensive humans. S. Laurent, B Caviezel, Laurent Beck, Hypertension	1994	255
Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration L. Bara, Eliane M. Billaud, G. Gramond, Thrombosis Research HepatologyMedicineUnfractionated HeparinHepatitisPharmacotherapy	1985	192
Therapeutic Drug Monitoring of Everolimus Maria Shipkova, Dennis A. Hesselink, David W. Holt, Therapeutic Drug Monitoring Pharmaceutical ScienceImmunologyPharmacotherapyImmunotherapyTranslational Pharmacology	2016	131
Noninvasive Measurement of Medium-Sized Artery Intima-Media Thickness in Humans: In vitro Validation Xavier Girerd, Jean‐Jacques Mourad, Christophe Acar, Journal of Vascular Research HypertensionMedical UltrasoundEngineeringSurgeryBiomedical Engineering	1994	92
A simple ultra-high-performance liquid chromatography-high resolution mass spectrometry assay for the simultaneous quantification of 15 antibiotics in plasma Sandrine Lefeuvre, J. Bois-Maublanc, Laurent Hocqueloux, Journal of Chromatography B Drug AnalysisAntimicrobial SusceptibilityAntibioticsMedicineMass Spectrometry	2017	83
Clinical risk factors for invasive aspergillosis in lung transplant recipients: Results of an international cohort study Claire Aguilar, Bassem Hamandi, Christine Fegbeutel, The Journal of Heart and Lung Transplantation Lung TransplantationInvasive AspergillosisTransplantationClinical EpidemiologyClinical Mycology	2018	73
Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients Marion Berge, R. Guillemain, V. Boussaud, Transplant Infectious Disease	2009	62
Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients Maud Berge, R. Guillemain, David‐Alexandre Trégouët, European Journal of Clinical Pharmacology Voriconazole ExposureRespiratory ToxicologyPharmacologyPulmonary PharmacologyPulmonary Fibrosis	2010	60
A Universal Formula Based on Cystatin C to Perform Individual Dosing of Carboplatin in Normal Weight, Underweight, and Obese Patients Antonin Schmitt, Laurence Gladieff, Amélie Lansiaux, Clinical Cancer Research	2009	57
Simultaneous determination of the acid/base antihypertensive drugs celiprolol, bisoprolol and irbesartan in human plasma by liquid chromatography Éric Caudron, Stéphane Laurent, Eliane M. Billaud, Journal of Chromatography B Medicinal ChemistryHypertensionPharmaceutical ScienceMedicineAntihypertensive Therapy	2003	56

Page 1